The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum - Wikidata - thesis-toulmin - TriplyDB

The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum

The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum

http://www.wikidata.org/entity/Q28219013

about

sameAs

Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways AF10-dependent transcription is enhanced by its interaction with FLRG Latent myostatin has significant activity and this activity is controlled more efficiently by WFIKKN1 than by WFIKKN2 Agrin binds BMP2, BMP4 and TGFbeta1 Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2 GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells Regulation of muscle growth by multiple ligands signaling through activin type II receptors.Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11 Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting Myostatin regulates cardiomyocyte growth through modulation of Akt signaling Meeting the meat: delineating the molecular machinery of muscle development Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment Myostatin: expanding horizons Pharmacology of manipulating lean body mass The Structure of FSTL3{middle dot}Activin A Complex: DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding Structure of Myostatin·Follistatin-like 3 Targeting of bone morphogenetic protein growth factor complexes to fibrillin Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration Identification and characterization of a leucine-rich repeat kinase 2 (LRRK2) consensus phosphorylation motif Presence, actions, and regulation of myostatin in rat uterus and myometrial cells Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting Genetic analysis of the role of proteolysis in the activation of latent myostatin Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.Structural basis for potency differences between GDF8 and GDF11.Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.Differential expression of follistatin and FLRG in human breast proliferative disorders Cytotoxic aggregation and amyloid formation by the myostatin precursor protein Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice Deep intronic mutation and pseudo exon activation as a novel muscular hypertrophy modifier in cattle Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.Myostatin expression, lymphocyte population, and potential cytokine production correlate with predisposition to high-fat diet induced obesity in mice.Transgenic engineering of male-specific muscular hypertrophy.Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complex.Lifelong exercise, but not short-term high-intensity interval training, increases GDF11, a marker of successful aging: a preliminary investigation.Obesity and low-grade inflammation increase plasma follistatin-like 3 in humans.The C313Y Piedmontese mutation decreases myostatin covalent dimerisation and stability.Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.

P2860

Q21090110-03EDCBD5-FA93-4075-BBBF-B9AD10014691 Q24293617-E6DB83E9-6CD6-4AB8-818A-4FA07D7EDDDB Q24297583-53CB6EBB-9D07-4D6B-B829-C0F4770CDC04 Q24315763-7B98BA71-FB82-4183-9BBB-C09C2F951DD3 Q24323503-05D50EB6-32A9-4F38-9190-952FDF870972 Q24531973-AD536A59-A7C2-4654-9A08-742D9C4F8C1A Q24538732-F16D5C2E-38EC-4F45-A73A-00AE851DB3FD Q24607839-4B49ED51-CAE8-434E-AA0C-549E1E61AF82 Q24609841-58320871-52CD-4061-943B-71D58F4068CF Q24614013-A1AD9804-A4B3-4DB3-9166-A99D487C96C7 Q26750626-5D6DB0A0-534C-46E4-B39F-0A1DA03F4C7A Q26775254-738FA9FA-5370-4781-99FB-10B37B33C502 Q26797484-34F71FE1-BBF7-4E76-9886-6C0AFD0AB783 Q26824503-92E8ED63-D390-425C-90C0-C8A7B2BCA557 Q27651961-4787CA3B-C3B3-4465-9D1C-F02EB367681F Q27656789-F0F6B2D1-14B9-4553-A615-E2A9B2E40C3C Q27675374-F5561321-DB1C-4F62-AE40-6167FB5A6D8C Q28118178-B81AEE33-12DF-4B8F-9D81-A45EF8FCD1C9 Q28240448-89366E5C-D0AD-4C4F-8BD7-90A34792DDF1 Q28262319-29C62EB4-ABFF-4601-B74A-826770CA2A6F Q28475942-285E48DA-D553-4065-A893-94EE8CBE32C4 Q28580010-60948E06-4A99-4A10-9D90-7A9FE2EA5D09 Q28588473-574A8EC9-EC0E-4E62-B3B4-91583FAB7512 Q28592774-AD9D32E4-5019-4FB5-9912-744BD58C002B Q30478055-0D0799AE-F95E-4444-AB03-CBD5B567F158 Q31813087-41E5174A-4A6B-4916-8B96-0240293B0FA2 Q33419373-59412877-5FC6-4D83-B323-8D2D7D6440FC Q33501385-FE78867F-E83F-4409-9CF4-3A03EB39884F Q33531807-AA37F49A-008B-43D5-AD89-C3FE151107CB Q33531816-8EDF164B-23A1-4DDD-8C39-98CFE6D27A8B Q33610303-CEB46257-3A28-4E38-9E20-9B6D56B9FC7B Q33642619-F047BDA6-6AE8-447F-8EC2-EF0C138DD1CE Q33705132-C580BE40-9188-4EEF-8639-619A4A4958CC Q33772180-5A39211E-97F1-4E44-B5F4-BEE070A667E1 Q33881904-D76AA6CC-C81D-4861-A801-9CD1A05B446A Q33883297-25DAF1F4-ED20-4883-BF5F-866D3A55132B Q33896134-76B64E11-5E0B-4B80-80A2-22EB1C22F88B Q33930386-E13CAA33-61B5-4914-A63E-A2350FEED3A7 Q34056750-2A70452A-821F-4E79-9967-DC5B1E1DE546 Q34126666-EAB13B1A-4911-4DCC-8063-25338AA758D6

P2860

The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum

http://www.wikidata.org/entity/Q28219013

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

The myostatin propeptide and t ...... s of myostatin in normal serum

@ast

The myostatin propeptide and t ...... s of myostatin in normal serum

@en

The myostatin propeptide and t ...... s of myostatin in normal serum

@nl

type

label

The myostatin propeptide and t ...... s of myostatin in normal serum

@ast

The myostatin propeptide and t ...... s of myostatin in normal serum

@en

The myostatin propeptide and t ...... s of myostatin in normal serum

@nl

prefLabel

The myostatin propeptide and t ...... s of myostatin in normal serum

@ast

The myostatin propeptide and t ...... s of myostatin in normal serum

@en

The myostatin propeptide and t ...... s of myostatin in normal serum

@nl

P1433

Q28219013-6AE1662F-8B94-41B9-A166-3710FF469A19

P1476

Q28219013-8D2D168C-4600-4437-AC44-38055050CE30

P2093

Q28219013-25B6EC9D-5905-4A14-BC8E-5B07C8325F5F

Q28219013-49A4AD07-737B-4D0E-8B46-8F1465EC1380

Q28219013-55706EB3-2464-40D1-BFF0-8D6D2B4941E3

Q28219013-701B7DC2-14D9-4B06-B065-2D913F6FAF30

Q28219013-712F140B-2A6B-4377-8073-9DF86181A804

Q28219013-A5F5E2F8-860E-44B6-966E-005F068C58E3

Q28219013-E5AB0D12-0845-4E8C-8EA0-B41BAC8349DD

P304

Q28219013-C21DFCE4-B864-4AA0-8681-67C03B9D17F5

P31

Q28219013-C8D4EACB-CFC5-433D-952E-C9911390F00E

P3181

Q28219013-21762971-181E-44BE-A7C6-CA9C491CC1CA

P356

Q28219013-C90E3DA2-2D20-481C-84B2-8FEF6937D6B5

P407

Q28219013-BC990DF3-678E-40FC-9F3B-417E0EC03D9D

P433

Q28219013-D9C972D5-99F3-4A64-90A8-0FAB48B05773

P478

Q28219013-9B6AE362-CCCE-4F68-9D43-D07D29395992

P577

Q28219013-23825A93-AFB2-4667-92A6-9E4BDA5735C5

P698

Q28219013-47C39D4D-AE93-4894-8C3D-92A636125C44

P3181

P356

P1433

Journal of Biological Chemistry

P1476

The myostatin propeptide and t ...... s of myostatin in normal serum

@en

P2093

Adele A Pearson

http://www.w3.org/2001/XMLSchema#string

Jack H Wang

http://www.w3.org/2001/XMLSchema#string

Jennifer J Hill

http://www.w3.org/2001/XMLSchema#string

Monique V Davies

http://www.w3.org/2001/XMLSchema#string

Neil M Wolfman

http://www.w3.org/2001/XMLSchema#string

Rodney M Hewick

http://www.w3.org/2001/XMLSchema#string

Yongchang Qiu

http://www.w3.org/2001/XMLSchema#string

P304

40735-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1247787

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M206379200

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12194980

http://www.w3.org/2001/XMLSchema#string